Meet Andria White
Founder & Principal Consultant
Senior clinical operations leader with 13+ years of experience leading global Phase I–III clinical trials, including oncology programs, in lean biotech environments. Proven expertise in leading cross-functional teams, managing CRO and alliance partnerships, and driving operational planning for program development and regulatory interactions.
Professional Background
Mariliam Clinical Research Consulting LLC is led by Andria White, a Certified Clinical Research Associate with demonstrated success in global study execution, risk management, and stakeholder collaboration. With a track record of delivering complex clinical programs on time and within budget, Andria provides a powerful blend of scientific acumen and operational execution.
Holding a Bachelor of Science in Biomedical Engineering from Tulane University, Andria brings rigorous analytical capabilities combined with deep practical experience across the clinical development lifecycle—from IND preparation through regulatory submissions and database lock.
Core Competencies
Operational Excellence
- End-to-end Phase I-III trial execution
- Study start-up & site management
- Budget & timeline ownership
- Cross-functional team leadership
Vendor & CRO Management
- Strategic RFP development & selection
- CRO oversight & performance tracking
- Alliance partner relationships
- Quality & compliance monitoring
Regulatory & Quality
- IND preparation & submission support
- Protocol & ICF development
- GCP & regulatory compliance
- QA audit management
People & Team Leadership
- Individual contributor or team leadership roles
- CRA team management & mentorship
- Cross-functional collaboration & facilitation
- Professional development & performance guidance
Recognition & Awards
🏆 Principles Award - HanAll Pharmaceutical (September 2025)
⭐ Star Award - I-Mab Biopharma (October 2022)
Career Highlights
Senior Manager, Clinical Operations
HanAll Pharmaceutical Inc. (Feb 2023 - Present)
- Led end-to-end operational planning and execution of Phase 1 SAD, MAD, and Food Effect studies in healthy volunteers
- Managed alliance partner relationships across clinical-stage programs in Myasthenia gravis, Thyroid eye disease, and Graves' disease in Japan
- Directed operational and country-selection strategy for Phase 2 Parkinson's program, ensuring protocol design aligned with enrollment feasibility
- Supported IND application preparation and submission for Parkinson's disease program
- Oversaw CRO and external consultants for ongoing US-based Phase 3 clinical trial in Dry eye disease
Senior Clinical Project Manager
I-Mab Biopharma (Sep 2022 - Feb 2023)
- Served as operational lead for Phase 2 oncology trial in ovarian cancer, accountable for timelines, budget, CRO oversight, and study deliverables
- Managed study team including internal CRAs and CTAs as well as external CRO resources
- Led cross-functional initiative to implement updated study start-up processes
Clinical Project Manager
I-Mab Biopharma (Sep 2019 - Aug 2022)
- Responsible for planning, implementation, and execution of Phase I clinical trial in severe COVID-19 patients
- Implemented eTMF system and refined internal Clinical Operations SOPs
- Developed RFPs and led selection of CROs, vendors, and investigational sites
Senior Clinical Research Associate
Novavax, Inc. (Dec 2016 - Aug 2017)
- Served as Global Lead CRA on Phase III RSV Maternal Immunization study across North America, South America, Asia-Pacific, and EU
- Selected 90 sites globally and led trainings at global Investigator Meetings
- Provided oversight of CRO resources to ensure adherence to timelines for site start-up, recruitment, and monitoring